Skip to main content

Table 5 Primary outcomes for patients with PSC

From: Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]

 

Placebo (n = 6)

Fluvoxamine (n = 5)

 

Day 0

Day 14

Day 42

Day 70

Day 0

Day 14

Day 42

Day 70

VAS Fatigue

7.3

7.4

7.5

8.3

6.4

6.8

7.5

7.9

FFSS

   Physical Domain

14

13

9

9

28

27

26

28

   Cognitive Domain

8

11

8

7

20

20

19

18

   Social Domain

17

12

11

13

48

49

47

48

MFI

   General Fatigue

18

18

17

17

19

19

19

20

   Physical Fatigue

13

15

14

13

18

19

19

19

   Reduction Activity

12

12

11

12

18

18

17

20

   Reduction Motivation

10

10

8

8

18

17

18

16

   Mental Fatigue

12

10

10

11

14

14

13

13

  1. Results are expressed as median scores.